Pharma sector will outperform broader markets: IIFL

Bino Pathiparampil of IIFL is overweight on pharma space. According to him, the sector will outperform the broader markets.

Pathiparampil told CNBC-TV18, “Pharma is one of our important sectors, one of the sectors in which we are overweight. We expect the sector to do well this year as well. Going forward beyond this year I am not expecting the kind of performance from the sector that we saw over the last 2-3 years, which was phenomenally good because that kind of the base is getting larger.”
“There could be some moderation in growth rates in the US as we pass the patent cliff etc. But still for this year definitely, the sector will outperform the broader markets. Going forward also, it will continue to give returns although at a slightly moderated pace,” Pathiparampil added.